Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine and pentazocine for prevention of shivering and traction pain after cesarean section anesthesia
ChiCTR2100054224Phase 4Recruiting
- Sponsor
- Xuzhou No. 1 People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine, pentazocine and dexmedetomidine in postanesthetic shivering (PAS) and postoperative pain (4 arms), sponsored by Xuzhou No. 1 People's Hospital. Primary endpoints: Shivering classification and Traction pain classification. Started Jun 2021; status: recruiting.
02
Drugs
nalbuphinepentazocinedexmedetomidine
03
Conditions
postanesthetic shivering (PAS)postoperative pain
Beyond the preview
Go deeper on ChiCTR2100054224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054224.